Advancing Glomerular Disease Care Through Autoantibody Biomarkers
- Highlighting the role of podocyte-targeting autoantibodies in monitoring disease activity and guiding treatment decisions
- Exploring novel biomarkers to enable earlier intervention and more precise therapeutic strategies
- Showcasing global centers of excellence and international collaborations in autoimmune glomerular disease research
- Discussing implications for pharmaceutical development and opportunities to accelerate drug discovery and clinical translation